Journals / BEYOGLU EYE JOURNAL / 2018 / Cilt: 3 - Sayı: 3

The Incidence of Retinopathy of Prematurity in a Tertiary Care Center in Turkey

Pages
128–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: As it was determined that the mean gestational age and weight were lower in infants with ROP than the infants with no ROP development, so the importance of the low birth weight and the gestational age was confirmed as risk factors for ROP development.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The objective of our study was to determine the incidence of retinopathy of prematurity (ROP) in our hos-pital, which gives tertiary health services.
📊
Key Findings & Data:Methods: In this retrospective study, the medical files of the infants, who were born before the 36th gestational age and applied for the examination of ROP between 2014 and 2017 to Istanbul Kanuni Sultan Suleyman Training and Re-search Hospital, were investigated.
💡
Conclusion & Impact:Conclusion: As it was determined that the mean gestational age and weight were lower in infants with ROP than the infants with no ROP development, so the importance of the low birth weight and the gestational age was confirmed as risk factors for ROP development.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: The objective of our study was to determine the incidence of retinopathy of prematurity (ROP) in our hos-pital, which gives tertiary health services. Methods: In this retrospective study, the medical files of the infants, who were born before the 36th gestational age and applied for the examination of ROP between 2014 and 2017 to Istanbul Kanuni Sultan Suleyman Training and Re-search Hospital, were investigated. The birth weight, gestational age, type of delivery, and the development of ROP were recorded. Results: The mean gestational age and mean birth weight of 2913 infants, who were screened for ROP, were 32.3±2.9 (22–36) weeks and 1846±580 g (360–4300), respectively. 48.7% of the patients were females and 51.3% were males. 32.4% of the patients had ROP at any stage. 8.8% of the infants had severe ROP and were treated accordingly. The mean gestational age and the mean gestational weight of the infants in this group were 28.0±2.6 weeks (22–35) and 1171.9±417.5 g (360–2500), respectively. The mean birth weight was lower in the severe ROP group compared to the group with no ROP development. 28 infants (0.9%) with birth weight over 2500 g (2502–3740) had only mild ROP and improved spontaneously. Conclusion: As it was determined that the mean gestational age and weight were lower in infants with ROP than the infants with no ROP development, so the importance of the low birth weight and the gestational age was confirmed as risk factors for ROP development.

🔖

Cite This Article

EKİNCİ, D. Y., BAYRAMOĞLU, S. E., VURAL, A. D. (2018). The Incidence of Retinopathy of Prematurity in a Tertiary Care Center in Turkey. BEYOGLU EYE JOURNAL, Cilt: 3 - Sayı: 3, 128–132. https://ajindex.com/articles/146242

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Terry TL. Fibroblastic overgrowth of persistent Tunica vascu-losa lentis in infants born prematurely: II. Report of cases-clini-cal aspects. Trans Am Ophthalmol Soc 1942;40:262–84.
  2. Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS 2012;16:501–7.
  3. Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the early treatment for retinopathy of prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004;102:233–48.
  4. Emsley HC, Wardle SP, Sims DG, Chiswick ML, D’Souza SW. Increased survival and deteriorating developmental outcome in 23 to 25 week old gestation infants, 1990-4 compared with 1984-9. Arch Dis Child Fetal Neonatal Ed 1998;78:F99–104. Quinn GE. Retinopathy of prematurity blindness worldwide: Phenotypes in the third epidemic. Eye Brain 2016;8:31–6.
  5. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs. Pediatrics 2005;115:e518–25. Onyango O, Sitati S, Amolo L, Murila F, Wariua S, Nyamu G, et al. Retinopathy of prematurity in Kenya: Prevalence and risk factors in a hospital with advanced neonatal care. Pan Afr Med J 2018;29:152. Zin A, Gole GA. Retinopathy of prematurity-incidence today. Clin Perinatol 2013;40:185–200.
  6. Zin AA, Magluta C, Pinto MF, Entringer AP, Mendes-Gomes MA, Moreira ME, et al. Retinopathy of prematurity screen-ing and treatment cost in Brazil. Rev Panam Salud Publica 2014;36:37–43.
  7. Bas AY, Koc E, Dilmen U, ROP Neonatal Study Group. Inci-dence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol 2015;99:1311–4. International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991–9. Fierson WM. American Academy of Pediatrics Section on Ophthalmology, American Academy of Ophthalmology, Amer-icanAssociation for Pediatric Ophthalmology and Strabismus, Ameri-can Association of Certified Orthoptists. Screening ex-amination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189–95.
  8. Gutierreza M, Olguín-Manríquezb FJ, Arriola-Lopezb AE, O’Hare JP, Raymond NT. Evidence to modify guidelines for routine retinopathy of prematurity screening to avoid child-hood bli